Transgenic animal models: New avenues in cardiovascular physiology

Journal of Molecular Medicine

Volumn 75, Issue 2, 1997, Pages 115-129

  Franz, W M ^a   Mueller, O J ^b   Hartong, R ^b   Frey, N ^b   Katus, H A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

cardiovascular diseases; disease models, animal; gene expression regulation; gene therapy; transgenic animals

Indexed keywords

ANIMAL MODEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DISEASE MODEL; GENE EXPRESSION REGULATION; GENE THERAPY; HUMAN; PHYSIOLOGY; REVIEW; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGY; DISEASE MODELS, ANIMAL; GENE DELETION; GENE EXPRESSION REGULATION; GENE THERAPY; HUMANS; MUTATION; PHENOTYPE;

EID: 0030896041     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050096     Document Type: Review

References (119)

1. Hasty P, Ramirez SR, Krumlauf R, Bradley A (1991) Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature 350:243-246
2. Geisterfer-Lowrance AAT, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG (1990) A molecular basis for familial hypertrophic cardiomyopathy: a β-cardiac myosin heavy chain gene missense mutation. Cell 62:999-1006
3. Keating MT, Sanguinetti MC (1996) Molecular genetic insights into cardiovascular disease. Science 272:681-685
4. Geisterfer-Lowrance AAT, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG (1996) A mouse model of familial hypertrophic cardiomyopathy. Science 272:731-734
5. Kuhn R, Schwenk F, Aguet M, Rajewski K (1995) Inducible gene targeting in mice. Science 269:1427-1429
6. Wobus AM, Rohwedel J, Maltsev V, Hescheler J (1995) Development of cardiomyocytes expressing cardiac-specific genes, action potentials, and ionic channels during embryonic stem cell-derived cardiogenesis. Ann NY Acad Sci 752:460-469
7. Franz WM, Breves D, Klingel K, Brem G, Hofschneider PH, Kandolf R (1993) Heart-specific targeting of firefly luciferase by the myosin light chain-2 promoter and developmental regulation in transgenic mice. Cire Res 73:629-638
8. Franz WM, Brem G, Katus HA, Klingel K, Hofschneider PH, Kandolf R (1994) Characterization of a cardiac-selective and developmentally upregulated promoter in transgenic mice. Cardioscience 5:235-243
9. Cui C, Wani MA, Wight D, Kopchick J, Stambrook PJ (1994) Reporter genes in transgenic mice. Transgenic Res 3:182-194
10. Seidman CE, Schmidt EV, Seidman JG (1991) cis-Dominance of rat atrial natriuretic factor gene regulatory sequences in transgenic mice. Can J Physiol Pharmacol 69:1486-1492
11. Lee KJ, Ross RS, Rockman HA, Harris AN, O'Brien TX, van Bilsen M, Shubeita HE, Kandolf R, Brem G, Price J, Evans SM, Zhu H, Franz WM, Chien KR (1992) Myosin light chain-2 luciferase transgenic mice reveal distinct regulatory programs for cardiac and skeletal muscle-specific expression of a single contractile protein gene. J Biol Chem 267:15875-15885
12. Rindt H, Gulick J, Knotts S, Neumann J, Robbins J (1993) In vivo analysis of the murine β-myosin heavy chain gene promoter. J Biol Chem 268:5332-5338
13. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J (1991) Tissue-specific regulation of the α-myosin heavy chain gene promoter in transgenic mice. J Biol Chem 266:24613-24620
14. Petropoulos CJ, Rosenberg MP, Jenkins NA, Copeland NG, Hughes SH (1989) The chicken skeletal muscle α-actin promoter is tissue specific in transgenic mice. Mol Cell Biol 9:3785-3792
15. Brennan KJ, Hardeman EC (1993) Quantitative analysis of the human α-skeletal actin gene in transgenic mice. J Biol Chem 268:719-725
16. Johnson JE, Wold BJ, Hauschka SD (1989) Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol Cell Biol 9:3393-3399
17. Parsons WJ, Richardson JA, Graves KH, Williams RS, Moreadith RW (1993) Gradients of transgene expression directed by the human myoglobin promoter in the developing mouse heart. Proc Natl Acad Sci USA 90:1726-1730
18. Kelly R, Alonso S, Tajbakhsh S, Cossu G, Buckingham M (1995) Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice. J Cell Biol 129:383-396
19. Gopal-Srivastava R, Haynes JH, Piatigorsky J (1995) Regulation of the murine aB-crystallin/small heat shock protein gene in cardiac muscle. Mol Cell Biol 15:7081-7090
20. Biben C, Hadchouel J, Tajbakhsh S, Buckingham M (1996) Developmental and tissue-specific regulation of the murine cardiac actin gene in vivo depends on distinct skeletal and cardiac muscle-specific enhancer elements in addition to the proximal promoter. Dev Biol 173:200-212
21. Zhu L, Lyons GE, Juhasz O, Joya JE, Hardeman EC, Wade R (1995) Developmental regulation of troponin I isoform genes in striated muscles of transgenic mice. Dev Biol 169:487-503
22. Harats D, Kurihara H, Belloni P, Oakley H, Ziober A, Ackley D, Cain G, Kurihara Y, Lawn R, Sigal E (1995) Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-I promoter. J Clin Invest 95: 1335-1344
23. Weiler-Guettler H, Aird WC, Husain M, Rayburn H, Rosenberg RD (1996) Targeting of transgene expression to the vascular endothelium of mice by homologous recombination of the thrombomodulin locus. Circ Res 78:180-187
24. Schlaeger TM, Qin Y, Fujiwara Y, Magram J, Sato TN (1995) Vascular endothelial cell lineage-specific promoter in transgenic mice. Development 121:1089-1098
25. Korhonen J, Lahtinen I, Halmekyto M, Alhonen L, Janne J, Dumont D, Alitalo K (1995) Endothelial-specific gene expression directed by the tie gene promoter in vivo. Blood 86: 1828-1835
26. Aird WC, Jahroudi N, Weiler-Guettler H, Rayburn HB, Rosenberg RD (1995) Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc Natl Acad Sci USA 92:4567-4571
27. Li L, Miano JM, Mercer B, Olson EN (1996) Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol 132:849-859
28. Mullins JJ, Sigmund CD, Kane Haas C, Wu CZ, Pacholec F, Zeng Q, Gross KW (1988) Studies on the regulation of renin genes using transgenic mice. Clin Exp Hypertens A 10:1157-1167
29. Mullins JJ, Peters J, Ganten D (1990) Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344:541-544
30. Fukamizu A, Seo MS, Hatae T, Yokoyama M, Nomura T, Katsuki M, Murakami K (1991) Tissue-specific expression of the human renin gene in transgenic mice. Biochem Biophys Res Commun 165:826-832
31. Sigmund CD, Jones CA, Kane CM, Wu C, Lang JA, Gross KW (1992) Regulated tissue- and cell-specific expression of the human renin gene in transgenic mice. Circ Res 70:1070-1079
32. Ganten D, Wagner J, Zeh K, Bader M, Michel JB, Paul M, Zimmermann F, Ruf P, Hilgenfeldt U, Ganten U, Kaling M, Bachmann S, Fukamizu A, Mullins JJ, Murakami K (1992) Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc Natl Acad Sci USA 89:7806-7810
33. Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo MS, Takahashi S, Hatae T, Kujiwara N, Yagami K, Murakami K (1993) Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 268:11617-11621
34. Ohkubo H, Kawakami H, Kakehi Y, Takumi T, Arai H, Yokota Y, Iwai M, Tanabe Y, Masu M, Hata J, Iwao H, Okamoto H, Yokoyama M, Nomura T, Katsuki M, Nakanishi S (1990) Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proc Natl Acad Sci USA 87:5153-5157
35. Steinhelper ME, Cochrane KL, Field LJ (1990) Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 16:301-307
36. Ogawa Y, Itoh H, Tamura N, Suga S, Yoshimasa T, Uehira M, Matsuda S, Shiono S, Nishimoto H, Nakao K (1994) Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest 93:1911-1921
37. Habener JF, Cwikel B, Hermann H, Hammer RE, Palmiter RD, Brinster RL (1988) Expression of a metallothionein-vasopressin fusion gene in transgenic mice produces hypervasopressinemia and manifestations of nephrogenic diabetes insipidus. Trans Assoc Am Physicians 101:155-162
38. +-proton exchanger. Circ Res 76:148-153
39. Liefeldt L, Bocker W, Schonfelder G, Zintz M, Paul M (1995) Regulation of the endothelin system in transgenic rats expressing the human endothelin-2 gene. J Cardiovasc Pharmacol 26 [Suppl]:S32-33
40. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239-242
41. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao WH, Kamada N, Jishage K, Ouchi Y, Azuma S, Toyoda Y, Ishikawa T, Kumada M, Yazaki Y (1994) Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368: 703-710
42. Alfie ME, Hess F, Carretero OA (1995) Assessing the role of kinins in blood pressure regulation in a new transgenic mouse. Circulation 92 [Suppl]: 1-553
43. Hofmann SL, Russell DW, Brown MS, Goldstein JL, Hammer RE (1988) Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice. Science 239:1277-1281
44. Callow MJ, Verstuyft J, Tangirala R, Palinski W, Rubin EM (1995) Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a). J Clin Invest 96:1639-1646
45. Purcell-Huynh DA, Farese RVJ, Johnson DF, Flynn LM, Pierotti V, Newland DL, Linton MF, Sanan DA, Young SG (1995) Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. J Clin Invest 95:2246-2257
46. Shimano H, Yamada N, Katsuki M, Shimada M, Gotoda T, Harada K, Murase T, Fukazawa C, Takaku F, Yazaki Y (1992) Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia. Proc Natl Acad Sci USA 89:1750-1754
47. Shimano H, Ohsuga J, Shimada M, Namba Y, Gotoda T, Harada K, Katsuki M, Yazaki Y, Yamada N (1995) Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. J Clin Invest 95:469-476
48. van der Vlijmen BJM, van den Maagdenberg AMJM, Gijbels MJJ, van der Boom H, HogenEsch H, Frants RR, Hofker MH, Havekes LM (1994) Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein ES-Leiden transgenic mice. J Clin Invest 93:1403-1410
49. Fazio S, Sanan DA, Lee Y-L, Ji Z-S, Mahley RW, Rall SCJ (1994) Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112, Cys 142). Arteriosler Thromb 14:1873-1879
50. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM (1991) Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 353:265-267
51. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92:883-893
52. Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468-471
53. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14:133-140
54. Williamson R, Lee D, Hagaman J, Maeda N (1992) Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-1. Proc Natl Acad Sci USA 89:7134-7138
55. Homanics GE, Smith TJ, Zhang SH, Lee D, Young SG, Maeda N (1993) Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice. Proc Natl Acad Sci USA 90:2389-2393
56. Conolly ESJ, Winfree CJ, Springer TA, Naka Y, Liao H, Yan SD, Stern DM, Solomon RA, Gutierrez-Ramos JC, Pinsky DJ (1996) Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion, role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest 97:209-216
57. Paigen B, Morrow A, Brandon C, Mitchell D, Holmes P (1985) Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57:65-73
58. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ (1993) Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91:2572-2579
59. Grossman M, Rader DJ, Muller DWM, Kolansky DM, Kozarsky K, Clark B Jr, Stein EA, Lupien PJ, Brewer HBJ, Raper SE, Wilson JM (1995) A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med 1:1148-1154
60. Mahley RW, Innerarity TL, Rall JSC, Weisgraber KH, Taylor JM (1990) Apolipoprotein E: genetic variants provide insight into its structure and function. Curr Opin Lipid 1:87-95
61. Fazio S, Lee YL, Ji ZS, Rall SC Jr (1993) Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E. J Clin Invest 92:1497-1503
62. Heckel JL, Sandgren EP, Degen JL, Palmiter RD, Brinster RL (1990) Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator. Cell 62:447-456
63. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419-424
64. Erickson LA, Fici GJ, Lund JE, Boyle TP, Polites HG, Marotti KR (1990) Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene. Nature 346:74-76
65. Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Mulligan RC, Collen D (1993) Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest 92:2756-2760
66. Aitken K, Peninger J, Mak T, Chow L, Dawood F, Wen WH, Martino T, Liu P (1994) Increased susceptibility to coxsackieviral myocarditis in IRF-1 transgenic knockout mice. Circulation 90 [Suppl]: 1-139
67. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T (1992) Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 359:693-699
68. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S (1993) Transforming growth factor β 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770-774
69. Martino T, Aitken K, Penninger J, Mak T, Sole MJ, Dawood F, Wen WH, Liu P (1995) Mice with p56lck T-lymphocyte tyrosine kinase kocked out are resistant to coxsackieviral myocarditis. Circulation 92 [Suppl]:1-787
70. Jackson T, Allard MF, Sreenan CM, Doss LK, Bishop SP, Swain JL (1990) The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol Cell Biol 10:3709-3716
71. Huen DS, Fox A, Kumar P, Searle PF (1993) Dilated heart failure in transgenic mice expressing the Epstein-Barr virus nuclear antigen-leader protein. J Gen Virol 74:1381-1391
72. Gruver CL, DeMayo F, Goldstein MA, Means AR (1993) Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrinology 133:376-388
73. 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA 91:10109-10113
74. Hunter JJ, Tanaka N, Rockman HA, Ross J, Chien KR (1995) Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem 270:23173-23178
75. Hirota H, Yoshida K, Kishimoto T, Taga T (1995) Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92:4862-4866
76. Hassankhani A, Steinhelper ME, Soonpaa MH, Katz EB, Taylor DA, Andrade-Rozental A, Factor SM, Steinberg JJ, Field LJ, Federoff HJ (1995) Overexpression of NGF within zhe heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells. Dev Biol 169:309-321
77. Edwards JG, Lyons GE, Micales BK, Malhotra A, Factor S, Leinwand LA (1996) Cardiomyopathy in transgenic myf5 mice. Circ Res 78:379-387
78. Reiss K, Cheng W, Ferber A, Kajstura J, Olivetti G, Homey CJ, Baserga R, Anversa P (1995) Overexpression of IGF-1 in the heart is coupled with myocyte proliferation in transgenic mice. Circulation 92 [Suppl]:1-370
79. Hein L, Stevens ME, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK (1995) Cardiac remodeling in transgenic mice expressing angiotensinogen AT1a receptors under control of the α-myosin heavy chain promoter. Circulation 92 [Suppl]: 1-63
80. Neumann J, Field LJ, Jones LR, Rockman HA (1995) Targeted overexpression of phospholamban to the atria alters contractile function. Circulation 92 [Suppl]:1-65
81. Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn IGW, Walsh RA, Kranias EG (1996) Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest 97:533-539
82. Muthuchamy M, Grupp IL, Grupp G, O'Toole BA, Kier AB, Boivin GP, Neumann J, Wieczorek DF (1995) Molecular and physiological effects of overexpressing striated muscle β-tropomyosin in the adult adult murine heart. J Biol Chem 270: 30593-30603
83. Vikstrom KL, Factor SM, Leinwand LA (1995) A murine model for hypertrophic cardiomyopathy. Z Kardiol 84 [Suppl 4]:49-54
84. Koch WJ, Rockman HA, Samama P, Hamilton R, Bond RA, Milano CA, Lefkowitz RJ (1995) Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 268:1350-1353
85. Rockman HA, Hamilton R, Rahman NU, Milano CA, Lefkowitz RJ, Koch WJ (1995) Dampened cardiac function in vivo in transgenic mice overexpressing GRK5, a G protein-coupled receptor kinase. Circulation 92 [Suppl]: 1-240
86. 1-adrenoceptors in transgenic mice. Cardiovasc Res 27:1606-1612
87. Rakusan K, Hrdina PW, Turek Z, Lakatta EG, Spurgeon HA, Wolford GD (1984) Cell size and capillary supply of the hypertensive rat heart: quantitative study. Basic Res Cardiol 79:389-395
88. McLenachan JM, Henderson E, Morris KI, Dargie HJ (1987) Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 317:787-792
89. Chalifour LE, Gomes ML, Wang NS, Mes Masson AM (1990) Polyomavirus large T-antigen expression in heart of transgenic mice causes cardiomyopathy. Oncogene 5:1719-1726
90. Katz E, Steinhelper ME, Daud A, Delcarpio JB, Claycomb WC, Field LJ (1992) Ventricular cardiomyocyte proliferation in transgenic mice expressing α-cardiac myosin heavy chain-SV40 T-antigen fusion genes. Am. J. Physiol. 262:H1867-H1876
91. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh S-M, Darbonne WC, Knutzon DS, Yen R, Chien KR, Baker JB, Wood WI (1995) Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 92:1142-1146
92. Thorburn A, Thorburn J, Chen S-Y, Powers S, Shubeita HE, Feramisco JR, Chien KR (1993) HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem 268:2244-2249
93. 1-adrenergic stimulation. J Biol Chem 269:13490-13496
94. Cox GA, Cole NM, Matsumura K, Phelps SF, Hauschka SD, Campbell KP, Faulkner JA, Chamberlain JS (1993) Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364:725-729
95. 2-adrenergic receptor. Science 264:582-586
96. 2-adrenergic receptor is associated with reduced phospholamban protein. J Clin Invest 97:1618-1623
97. Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM, Dillmann WH (1995) Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 95: 1446-1456
98. Plumier JC, Ross BM, Currie RW. Angelidis CE, Kazlaris H, Kollias G, Pagoulatos GN (1995) Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest 95:1851-1860
99. Radford NB, Fina M, Benjamin IJ, Moreadith RW, Graves KH, Zhao P, Gavva S, Wiethoff A, Sherry AD, Malloy CR, Williams RS (1996) Cardioprotective effects of 70-kDa heat shock protein in transgenic mice. Proc Natl Acad Sci USA 93:2339-2342
100. Chen EP, Bittner HB, Davis RD, Van Trigt P, Folz RJ (1995) Extracellular superoxide dismutase overexpression improves post-ischemic myocardial function in isolated murine hearts. Circulation 92 [Suppl]: 1-514
101. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG (1994) Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res 75:401-409
102. Luo W, Wolska BM, Grupp IL, Harrer JM, Haghighi K, Ferguson DG, Slack JP, Grupp G, Doetschman T, Solaro RJ, Kranias EG (1996) Phospholamban gene dosage effects in the mammalian heart. Circ Res 78:839-847
103. Lembo G, Rockman HA, Hunter JJ, Powell-Braxton L, Chien KR (1994) Enhanced cardiac contractility in IGF-1 knockout mice. Circulation 90 [Suppl]: 1-194
104. Beckmann RP, Mizzen LA, Welch WJ (1990) Interaction of hsp70 with newly synthesized proteins: implications for protein folding and assembly. Science 248:850-854
105. Beckmann RP, Lovett M, Welch WJ (1992) Examining the function and regulation of hsp70 in cells subjected to metabolic stress. J. Cell Biol. 117:1137-1150
106. Georgopoulos C, Welch WJ (1993) Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol 9:601-634
107. Lee SW, Tsou A-P, Chan H, Thomas J, Petrie K, Eugui EM, Allison AC (1988) Glucocorticoids selectivly inhibit the transcription of the interleukin1-b gene and decrease the stability of interleukin 1-β mRNA. Proc Natl Acad Sci USA 85:1204-1208
108. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-5551
109. Furth PA, St-Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, Hennighausen L (1994) Temporal control of gene exprssion in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 91:9302-9306
110. Fishman GI, Kaplan ML, Buttrick PM (1994) Tetracyeline-regulated cardiac gene expression in vivo. J Clin Inv 93: 1864-1868
111. Yu Z, Fishman GI (1995) Quantitative analysis of tetracycline-regulated gene expression in the hearts of transgenic mice. Circulation 92 [Suppl]: 1-758
112. Gossen M, Freundlieb S, Bender G, Müller G, Hillen W, Bujard H (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769
113. Christopherson KS, Mark MR, Bajaj V, Godowski PJ (1992) Ecdysteroid-dependent regulation of genes in mammalian cells by Drosophila ecdysone receptor and chimeric transactivators. Proc Natl Acad Sci USA 89:6314-6318
114. No D, Yao T-P, Evans RM (1996) Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 93:3346-3351
115. Gu H, Marth JD, Orban PC, Mossmann H, Rajewski K (1994) Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 265: 103-106
116. Metzger D, Clifford J, Chiba H, Chambon P (1995) Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci USA 92:6991-6995
117. Bronson SK, Smithies O (1994) Altering mice by homologous recombination using embryonic stem cells. J Biol Chem 269:27155-27158
118. Gu H, Zou Y-R, Rajewsky K (1993) Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP mediated gene targeting. Cell 73:1155-1164
119. Hanks M, Wurst W, Anson-Cartwright L, Auerbach AB, Joyner AL (1995) Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science 269:679-682